Calcinosis: Clinical Trials

2 trials for Calcinosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2

Follow Calcinosis: new trials by email Literature Review of Calcinosis trials Research Report on Calcinosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intralesional Injection of STS in Treatment of Calcinosis
Sodium Thiosulfate (STS) - Systemic Sclerosis (SSc), Dermatomyositis
Phase 2RecruitingRobyn T. Domsic, MD, MPH202025-03-172026-05-05
Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
Rifampin - Idiopathic Infantile Hypercalcaemia - Severe Form, Genetic Disease
Phase 2RecruitingChildren's Hospital of Philadelphia602018-07-252026-10-13

Narrower conditions

Dermatomyositis (1)  ·  Genetic Diseases, Inborn (1)  ·  Hypercalcemia (1)  ·  Hypercalcemia, Idiopathic, of Infancy (1)  ·  Hypercalciuria (1)  ·  Hypercalciuric Hypercalcemia (1)  ·  Mixed Connective Tissue Disease (1)  ·  Nephrocalcinosis (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Calcium Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Myositis (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)

Interventions

Rifampin (1)  ·  sodium thiosulfate (1)

Sponsors

Children's Hospital of Philadelphia (1)  ·  Robyn T. Domsic, MD, MPH (1)

Countries

United States (2)

Top investigators

Michael A Levine, MD (1)  ·  Robyn T Domsis, MD (1)

Results publications

PMID 15942915, PMID 22227955

NIH funding

P50AR080612 (1), R01DK112955 (1)